Active Ingredient History
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Acute-On-Chronic Liver Failure (Phase 1/Phase 2)
Alzheimer Disease (Phase 1/Phase 2)
Colitis, Ulcerative (Phase 1)
Coronavirus (Phase 1)
COVID-19 (Phase 2)
Crohn Disease (Phase 1/Phase 2)
Dry Eye Syndromes (Phase 1/Phase 2)
Dyspnea (Phase 1/Phase 2)
Graft Rejection (Early Phase 1)
Healthy Volunteers (Phase 1)
Infections (Phase 1/Phase 2)
Inflammatory Bowel Diseases (Phase 1)
Irritable Bowel Syndrome (Phase 1)
Ischemic Stroke (Phase 1)
Liver Cirrhosis (Phase 2)
Liver Failure, Acute (Phase 1/Phase 2)
Myocardial Infarction (Phase 1/Phase 2)
Myocardial Ischemia (Phase 1/Phase 2)
Myocardial Stunning (Phase 1/Phase 2)
Osteoarthritis, Knee (Phase 1)
Periodontitis (Early Phase 1)
Pharmacology (Phase 1/Phase 2)
Pneumonia (Phase 1/Phase 2)
Rectal Fistula (Phase 1/Phase 2)
Respiratory Distress Syndrome (Phase 3)
Retinal Perforations (Early Phase 1)
Severe Acute Respiratory Syndrome (Phase 3)
Ulcer (Early Phase 1)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue